Article Information
vol. 11 no. 475
- Received for publication March 2, 2017
- Resubmitted June 7, 2018
- Accepted for publication December 10, 2018
- .
Author Information
- Adrian Vella1,
- Jennifer L. R. Freeman2,
- Imogene Dunn2,
- Kit Keller2,
- John B. Buse3 and
- Carmen Valcarce2,*
- 1Division of Endocrinology and Diabetes, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
- 2vTv Therapeutics Inc. and vTv Therapeutics LLC, High Point, NC 27265, USA.
- 3Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
- ↵*Corresponding author. Email: cvalcarce{at}vtvtherapeutics.com